Notice of Annual General Meeting 2024

This year's Annual General Meeting will be held at

The King's Fund, No. 11 Cavendish Square, London W1G 0AN on Thursday, 25 July 2024 at 12.30pm ('AGM')

This Notice of Meeting sets out the resolutions that shareholders are being asked to consider and vote on at the AGM of Halma plc (the 'Company'). The Board recognises the importance of the AGM to our investors and all shareholders are urged to vote, whether or not you plan to attend.

Shareholders are encouraged to appoint the Chair

of the meeting as their proxy. It is recommended that shareholders submit their Proxy Form as early as possible to ensure that their votes are counted at the AGM.

If you are unable to attend the AGM in person, you can vote on the resolutions put to shareholders either online or by post as follows:

Online: if you have accessed this Notice of Meeting electronically or wish to vote online, go to www.investorcentre.co.uk/eproxy and follow the instructions.

By post: if you have received the Annual Report and Accounts 2024 or a notification that it is available to be viewed on the Company's website, you will also have received a Proxy Form. Instructions on voting can be found on the Proxy Form.

Please note that a printed copy of the Annual Report and Accounts 2024 will only be sent to you if you have opted to receive paper copies of such documents or if you have recently acquired shares.

Otherwise you may now access the Annual Report and Accounts 2024 by visiting our website at www.halma.com.

AGM Arrangements

The AGM will be held at The King's Fund, No. 11 Cavendish Square, London W1G 0AN, shown on the map below. The meeting will commence at 12.30pm with doors opening from 12.00 noon.

Shareholders are invited to submit any questions regarding the formal business of the AGM via email to AGM@halma.com. Any questions received by 12.30pm on 23 July 2024 will be grouped thematically and responses published on our website prior to the AGM. Any questions received after this date will be addressed either at the AGM, on the Company's website or in private correspondence.

The results of voting on all resolutions at the AGM will be released via a Regulatory Information Service and published on the Company's website as soon as possible after the AGM.

Should it become necessary to revise the current arrangements for the AGM, the Company will communicate any such changes to shareholders through a Regulatory Information Service and through the Company's website at www.halma.com.

This document is important and requires your immediate attention

Regent's Park

The King's FundStation

entrance in Dean's Mews

If you are in any doubt as to the action you should take, you should consult your stockbroker, bank manager, solicitor, accountant or other independent adviser authorised under the Financial Services and Markets Act 2000.

If you have sold or otherwise transferred all your shares in the Company, you should send this document, together with the Proxy Form, as soon as possible

to the purchaser or transferee, or to the stockbroker,

W

i

m

p

o

le

Stree

t

t

ee

tr

S

e

or

m

ig

W

Harley

S

t re

e

t

L

a

n

C

g

h

h

n

a

m

a

d

P

os

l

D

a

e

c

a

S

e

n'

r

t

s

e

M

e

t

e

ws

Cavendish

Re

g

Square

t

ent

ee

St

Str

et

r

ar

e

g

ar

M

et

bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

ce

la

P

tta

rie

en

John Lewis

H

t

ee

rdStr

fo

Ox

Bond Street

Station

Oxford Circus

Station

Halma plc |  Notice of Annual General Meeting 2024    01

NOTICE OF ANNUAL GENERAL MEETING

NOTICE IS HEREBY GIVEN that the Annual General Meeting of Halma plc will be held at The King's Fund, No. 11 Cavendish Square, London W1G 0AN on Thursday, 25 July 2024 at 12.30pm for the following purposes.

To consider and, if thought fit, pass resolutions 1 to 18 as ordinary resolutions and resolutions 19 to 22 as special resolutions:

Ordinary Resolutions

Annual Report and Accounts

1. To receive the Accounts and the Reports of the Directors (including the Strategic Report) and the Auditor for the year ended 31 March 2024.

Dividend

2. To declare a final dividend of 13.20p per share for the year ended 31 March 2024, payable on 16 August 2024 to shareholders who are on the Register of Members as at the close of business on 12 July 2024.

Remuneration Report

3. To approve the Remuneration Report for the year ended 31 March 2024 as set out on pages 152 to 157 and

166 to 177 of the Annual Report and Accounts 2024.

Remuneration Policy

4. To approve the Remuneration Policy as set out on pages 158 to 165 of the Annual Report and Accounts 2024, to take effect immediately after the conclusion of the meeting.

Directors

  1. To elect Liam Condon as a Director of the Company.
  2. To elect Giles Kerr as a Director of the Company.
  3. To re-elect Dame Louise Makin as a Director of the Company.
  4. To re-elect Marc Ronchetti as a Director of the Company.
  5. To re-elect Steve Gunning as a Director of the Company.
  6. To re-elect Jennifer Ward as a Director of the Company.
  7. To re-elect Carole Cran as a Director of the Company.
  8. To re-elect Jo Harlow as a Director of the Company.
  9. To re-elect Dharmash Mistry as a Director of the Company.
  10. To re-elect Sharmila Nebhrajani OBE as a Director of the Company.

Auditor

  1. To re-appoint PricewaterhouseCoopers LLP as Auditor of the Company, to hold office until the conclusion of the next annual general meeting of the Company.
  2. To authorise the Directors, acting through the Audit Committee, to determine the remuneration of the Auditor.

Authority to allot shares

17. That the Directors be and are hereby generally and unconditionally authorised pursuant to Section 551

of the Companies Act 2006 (the '2006 Act') to exercise all the powers of the Company to allot shares, or grant rights to subscribe for or to convert securities into shares, up to an aggregate nominal amount of £12,500,000 and that this authority shall expire on the earlier of (i) the conclusion of the annual general meeting of the Company to be held in 2025 and (ii)

30 September 2025 (unless previously renewed, varied or revoked by the Company in general meeting), save that the Company may before such expiry make any offer or agreement which would or might require shares to be allotted or such rights to be granted after such expiry and the Directors may allot shares or grant such rights in pursuance of such offer or agreement as if the authority conferred by this resolution had not expired.

Political donations and expenditure

18. That, in accordance with Sections 366 and 367 of the 2006 Act, the Company and any company which is, or becomes, a subsidiary of the Company at any time during the period for which this resolution has effect, be authorised to:

  1. make political donations to political parties and/or independent election candidates not exceeding £100,000 in total;
  2. make political donations to political organisations, other than political parties, not exceeding £100,000 in total; and
  3. incur political expenditure not exceeding £100,000 in total,

(as such terms are defined in Part 14 of the 2006 Act) during the period beginning on the date of the passing of this resolution and ending on the earlier of (i) the conclusion of the annual general meeting of the Company to be held in 2025 and (ii) 30 September 2025, provided that the aggregate amount of all political donations and political expenditure made

or incurred under paragraphs a., b. and c. above shall not exceed £100,000 in total.

02    Halma plc | Notice of Annual General Meeting 2024

Special Resolutions

Disapplication of pre-emption rights

19. That, subject to the passing of resolution 17, the Directors be given power to allot equity securities (as defined in Section 560 of the 2006 Act) of the Company for cash under the authority given by that resolution and/or to sell ordinary shares (as defined in Section 560 of the 2006 Act) held by the Company as treasury shares for cash as if Section 561 of the 2006 Act did not apply to any such allotment or sale, provided that such power shall be limited to:

  1. the allotment of equity securities and/or sale of treasury shares in connection with an offer of, or invitation to apply for, equity securities: (i) to ordinary shareholders on a fixed record date where the equity securities attributable to such ordinary shareholders are proportionate (as nearly as may be practicable) to their existing holdings; and
    (ii) to holders of other equity securities, as required by the rights of those securities, or as the Directors otherwise consider necessary, but subject to such exclusions or other arrangements as the Directors may deem necessary or expedient to deal with treasury shares, fractional entitlements, record dates, or legal, regulatory or practical problems arising in, or under the laws of, any overseas territory, the requirements of any regulatory body or stock exchange or any other matter whatsoever; and
  1. otherwise than pursuant to sub-paragraph a. above, the allotment of equity securities and/or sale of treasury shares, up to an aggregate nominal amount of £1,890,000;

and that this authority shall expire (unless previously renewed, revoked or varied by the Company in general meeting) when the authority conferred on the Directors in resolution 17 expires, save that the Company may make any offer or agreement before such expiry which would or might require equity securities to be allotted or equity securities held as treasury shares to be sold after such expiry and the Directors may allot equity securities and/or sell equity securities held as treasury shares in pursuance of such offer or agreement as if the power conferred by this resolution had not expired.

Additional disapplication of pre-emption rights

20.That, subject to the passing of resolution 17 and in addition to any authority granted under resolution 19, the Directors be given power to allot equity securities (as defined in Section 560 of the 2006 Act) of the Company for cash under the authority given by resolution 17 and/or to sell ordinary shares (as defined in Section 560 of the 2006 Act) held as treasury shares for cash, as if Section 561 of the 2006 Act did not apply to any such allotment or sale, provided that such power shall be:

  1. limited to the allotment of equity securities and/or sale of treasury shares up to an aggregate nominal amount of £1,890,000; and
  2. used only for the purposes of financing (or refinancing, if the authority is to be used within 12 months of the original transaction taking place) a transaction which the Directors determine to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by
    the Pre-Emption Group prior to the date of this Notice of Meeting;

and that this authority shall expire (unless previously renewed, revoked or varied by the Company in general meeting) when the authority conferred on the Directors in resolution 17 expires, save that the Company may make any offer or agreement before such expiry which would or might require equity securities to be allotted or equity securities held as treasury shares to be sold after such expiry and the Directors may allot equity securities and/or sell equity securities held as treasury shares in pursuance of such offer or agreement as if the power conferred by this resolution had not expired.

Halma plc |  Notice of Annual General Meeting 2024    03

NOTICE OF ANNUAL GENERAL MEETING continued

Authority to purchase own shares

21. That the Company be and is hereby generally and unconditionally authorised to make one or more market purchases (as defined in Section 693(4) of the 2006 Act) of its ordinary shares of 10p each ('ordinary shares') provided that:

  1. the maximum number of ordinary shares hereby authorised to be purchased is 37,900,000 ordinary shares, having an aggregate nominal value of £3,790,000;
  2. the maximum price (excluding expenses) which may be paid for an ordinary share is the higher of (i) an amount equal to 105% of the average market value of an ordinary share (derived from the London Stock Exchange Daily Official List) for the five business days immediately preceding the date on which that ordinary share is contracted to be purchased; and (ii) the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venues where the purchase is carried out at the relevant time; and
  3. the minimum price which may be paid for an ordinary share (excluding expenses) is the nominal value of an ordinary share;

and the authority hereby conferred shall expire (unless such authority is renewed by the Company in general meeting prior to such time) on the earlier of

  1. the conclusion of the annual general meeting of the Company to be held in 2025 and (ii) 30 September 2025, save that the Company may before such expiry enter into a contract for the purchase of ordinary shares which would or might be completed wholly or partly after such expiry and the Company may purchase ordinary shares pursuant to any such contract as if this authority had not expired.

Notice of general meetings

22. That a general meeting of the Company, other than an annual general meeting, may be called on not less than 14 clear days' notice.

Recommendation

The Directors believe that each of the resolutions to be put to the meeting is in the best interests of the Company and its shareholders as a whole and unanimously recommend that shareholders vote in favour of them, as they intend to do in respect of their own beneficial shareholdings in the Company.

By order of the Board

Mark Jenkins Company Secretary

13 June 2024

Registered office: Halma plc

Misbourne Court, Rectory Way Amersham, Buckinghamshire HP7 0DE

Registered in England and Wales No. 40932

04    Halma plc | Notice of Annual General Meeting 2024

NOTES ON THE RESOLUTIONS

Resolutions 1 to 18 will be proposed as ordinary resolutions which require a simple majority of the votes to be cast in favour of each resolution to be passed. Resolutions 19 to 22 will be proposed as special resolutions which require at least 75% of the votes to be cast in favour of each resolution to be passed.

Resolution 1 - Annual Report and Accounts

The Directors are required by the 2006 Act to present the audited accounts of the Company to shareholders at a general meeting, together with reports of the Directors (including the Strategic Report) and the Auditor (in this case for the year ended 31 March 2024). As a matter of best practice, these are put to shareholders for approval.

Resolution 2 - Final Dividend

This resolution seeks authority for the Company to pay a final dividend of 13.20p per share to shareholders for the financial year ended 31 March 2024, as recommended by the Directors. If approved, the dividend will be paid on 16 August 2024 to shareholders on the Register of Members at the close of business on 12 July 2024.

The Company offers a Dividend Reinvestment Plan ('DRIP') to enable shareholders to elect to have their cash dividends reinvested in Halma plc shares. Shareholders who wish

to opt for the DRIP for the forthcoming final dividend, but have not already done so, should return a DRIP mandate form to the Company's Registrar no later than 26 July 2024.

Resolution 3 - Remuneration Report

Section 439 of the 2006 Act requires that the Remuneration Report is put to a vote of shareholders at each general meeting at which accounts of the Company are presented. The Remuneration Report is set out on pages 152 to 157 and 166 to 177 of the Annual Report and Accounts 2024.

In accordance with the 2006 Act, the vote on this resolution is advisory and no remuneration is conditional on this resolution being passed.

Resolution 4 - Remuneration Policy

The purpose of resolution 4, which is proposed as an ordinary resolution, is to invite shareholders to approve the Directors' Remuneration Policy (the 'Policy'). The vote on the Policy is a binding vote. If resolution 4 is passed, the Policy shall take effect immediately after the end of the AGM (the 'Effective Date'), meaning that from the Effective Date the Company may not make a remuneration payment or a payment for loss of office to a person who is, is to be, or has been a Director of the Company unless the payment is consistent with the Policy, or has been otherwise approved by shareholder resolution. If the Policy is not approved for any reason, the Company will, if and to the extent permitted by the 2006 Act, continue to make payments to Directors in accordance with the existing Policy and will seek shareholder approval for a further revised Policy as soon as is practicable.

If approved by shareholders, the Policy will be subject to a binding shareholder vote by ordinary resolution in a further three years (in accordance with the 2006 Act), except in the event that a change to the Policy is proposed or the advisory vote on the Remuneration Report is not passed in any year subsequent to the approval of the Policy.

As described in the Remuneration Report, the Remuneration Committee discussed the details of the Policy over a series of meetings, to assess whether the 2021 remuneration policy remains appropriate and relevant in the context

of the Company's strategic plan and business goals set against a changing macro economic environment.

With support from internal experts and external advisers, the Remuneration Committee concluded that the 2021 remuneration policy remains appropriate, so the overall structure remains unchanged from that policy. Only minor editorial amendments have been made for administrative reasons. The Policy is set out on pages 158 to 165 of the Annual Report and Accounts 2024.

Resolutions 5 to 14 - Election and Re-Election of Directors

The Company's Articles of Association require, and the UK Corporate Governance Code recommends, that each Director retire at the Annual General Meeting and seek re-election.

All of the Directors seeking re-election have been subject to a performance evaluation. Based on that evaluation, it is considered that each Director continues to be effective and demonstrates the level of commitment required in connection with their role and the needs of the business. The Board, on the recommendation of the Nomination Committee, supports the election and re-election of each of the Directors.

It is the Board's view that each Director's contribution is, and continues to be, important to the Company's long-term sustainable success, as described in each Director's biography set out below.

Halma plc |  Notice of Annual General Meeting 2024    05

NOTES ON THE RESOLUTIONS continued

Biography for Directors for election

Liam Condon

Independent non-executive Director

A N R

Appointed: September 2023

Career and experience: Liam is Chief Executive of Johnson Matthey plc and brings a wealth of experience gained across a variety of roles, with a strong global background in driving growth and sustainability in the Life Science, Chemical and Energy Transition Industries. Earlier in his career, Liam held senior positions within Bayer AG and Schering AG.

Current appointments:

Johnson Matthey plc, Chief Executive

Giles Kerr

Independent non-executive Director

A N R

Appointed: February 2024

Career and experience: Giles has held a range of executive and non-executive positions across life sciences, technology and industrial businesses and brings extensive M&A and strategic business growth experience. His executive career included senior financial roles at Arthur Andersen (latterly as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at the University of Oxford. Since 2006, Giles has held a number of non- executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford University Innovation ltd, Oxford Sciences Innovation plc, Arix Bioscience plc, Senior plc and Abcam plc. He is currently Chair of PayPoint plc.

Current appointments:

PayPoint plc, Chair

Biography for Directors for re-election

Dame Louise Makin

Chair

N R

Appointed: February 2021 (July 2021 as Chair)

Career and experience: Louise is an experienced executive and board director, having led businesses across multiple sectors. She was the Chief Executive Officer of BTG plc, the international specialist healthcare company, from

2004 to 2019. Louise led the transformation of the company through a combination of organic growth and acquisitions, and significantly increased its market capitalisation before its sale in 2019. She previously served as a non-executive Director of Premier Foods plc, Woodford Patient Capital Trust plc and Intertek Group plc, and as a director of several not-for-profit organisations. Louise brings a wealth of leadership and international experience to the Board.

Marc Ronchetti

Group Chief Executive

Appointed: July 2018 (April 2023 as Group Chief Executive)

Career and experience: Marc was appointed Group Chief Executive in April 2023. He joined Halma in 2016 as Group Financial Controller and was promoted to the plc and Executive Board as Group CFO in July 2018. Marc brings a proven ability to drive business growth. He has played a vital role in evolving the Group's Sustainable Growth Model, purpose and culture, and has overseen a significant number of acquisitions while supporting Halma's companies to grow. Marc was previously the Finance Director of the UK operations of Wolseley plc (now Ferguson plc) and prior to that held various group and divisional roles at Inchcape plc.

Steve Gunning Chief Financial Officer

Appointed: January 2023

Career and experience: Steve joined Halma in 2023 as Chief Financial Officer. He was previously CFO of International Airlines Group and prior to that held several senior commercial and finance roles within IAG, including CFO of British Airways and Chief Executive of IAG Cargo. Steve was also a non-executive Director at FirstGroup plc. Earlier in his career, Steve worked in range of finance and audit roles in the UK and US at PricewaterhouseCoopers.

Jennifer Ward

Group Talent, Culture and Communications Director Appointed: September 2016

Career and experience: Jennifer joined the Halma Executive Board in March 2014 and has global responsibility for talent and culture as well as internal and external communications and brand across Halma. Prior to joining Halma as Group Talent Director, Jennifer spent over 15 years leading Human Resources, Talent and Organisational Development for divisions of PayPal, Bank of America and Honeywell. Jennifer brings a wealth of experience to the Board to ensure we secure and develop talent ahead of our growth needs and build a sustainable culture of

high performance.

Current appointments:

Diploma plc, Non-executive director

Committee Membership

AAudit Committee  NNomination Committee  RRemuneration Committee 

  Chair of Committee 

  Member of Committee

06    Halma plc | Notice of Annual General Meeting 2024

Carole Cran

Independent non-executive Director

A N R

Appointed: January 2016

Career and experience: Carole was Chief Financial Officer of Aggreko plc until December 2017, prior to which she held a number of senior finance roles within that group. Previously, she worked at BAE Systems plc in a range of senior financial positions, which included four years in Australia. Carole commenced her career in the audit division of KPMG where she qualified as a Chartered Accountant. Carole has extensive financial experience and has a strong focus on governance and risk.

Current appointments:

Forth Ports Limited, Chief Financial and

Commercial Officer

Jo Harlow

Senior Independent Director

A N R

Appointed: October 2016 (August 2023 as Senior Independent Director)

Career and experience: Jo has significant international experience, gained most recently as Corporate Vice President of the Phones Business Unit at Microsoft. She previously worked at Nokia as Executive Vice President of Smart Devices. Before her move into consumer electronics, Jo worked in strategic marketing at Reebok and Procter & Gamble. Jo brings a wealth of expertise to the Board in digital, technology, sales and marketing. She is Chair of the Remuneration Committee, and member of the Corporate Responsibility & Sustainability Committee, at

J Sainsbury plc. Jo was previously Chair of the Remuneration Committee at InterContinental Hotels Group plc, and

a Member of the Supervisory Board at Ceconomy AG.

Current appointments:

J Sainsbury plc, Non-executive director

Chapter Zero, Member of the Board

Centrica plc, Non-executive director

Dharmash Mistry

Independent non-executive Director

A N R

Appointed: April 2021

Career and experience: Dharmash is an experienced technology venture capitalist, entrepreneur and non- executive director. He was formerly a Partner at Balderton

  • Lakestar, an executive at Emap PLC and worked earlier in his career at The Boston Consulting Group and as a Brand Manager at Procter & Gamble. Dharmash was formerly a founder of blow LTD, which he chaired, and has served as a non-executive director at The British Business Bank, BBC, Hargreaves Lansdown PLC and Dixons Retail PLC.

Current appointments:

The Premier League, Non-executive director Rathbones Group plc, Non-executive director The FA, Non-executive director

Competition & Markets Authority, Non-executive director

Sharmila Nebhrajani OBE

Independent non-executive Director

A N R

Appointed: December 2021

Career and experience: Sharmila brings extensive private and public sector experience from her executive and non-executive roles in health, media and sustainability. She began her career at PwC, qualifying as a Chartered Accountant, and served with the BBC for 15 years, latterly as Chief Operating Officer of BBC New Media, the division that built the iPlayer. Sharmila was Chief Executive of Wilton Park, an ambassador level role in the Foreign and Commonwealth Office, focused on topics such as global health, climate risk and national security. She has held executive board positions at the Medical Research Council, the Association of Medical Research Charities and the NHS and was appointed OBE for services to medical research.

Current appointments:

ITV plc, Non-executive director

Severn Trent plc, Non-executive director Coutts & Co, Non-executive director

National Institute for Health and Care Excellence, Chair

Committee Membership

AAudit Committee  NNomination Committee  RRemuneration Committee    Chair of Committee    Member of Committee

Halma plc |  Notice of Annual General Meeting 2024    07

NOTES ON THE RESOLUTIONS continued

Resolution 15 - Re-appointment of Auditor

The Company is required under the 2006 Act to appoint an auditor at every general meeting at which accounts are presented, to hold office until the conclusion of the next general meeting at which accounts are presented. The Directors are proposing the reappointment of PricewaterhouseCoopers LLP as the Company's Auditor. The proposal to re-appoint PricewaterhouseCoopers LLP as the Company's Auditor is based on a recommendation from the Audit Committee, is free from third party influence and is not subject to any restrictive contractual arrangements.

Resolution 16 - Auditor's remuneration

In accordance with standard practice, this resolution gives authority to the Directors, acting through the Audit Committee, to determine the Auditor's remuneration for the next financial year.

Resolution 17 - Authority to allot shares

The purpose of this resolution is to renew the Directors' authority to allot shares. This resolution would allow the Directors to allot shares and grant rights to subscribe for or convert any securities into shares up to an aggregate nominal value of £12,500,000, being just less than one third of the total issued share capital of the Company (excluding treasury shares) as at 13 June 2024 (being the latest practicable date prior to the publication of the Notice of Meeting). The Company currently does not hold any shares in treasury.

In accordance with the Directors' stated intention to seek annual renewal, the authority will expire on the earlier of

  1. the conclusion of the annual general meeting of the Company in 2025 and (ii) 30 September 2025. Passing this resolution will give the Directors flexibility to act in the best interests of shareholders, when opportunities arise. The Directors have no current plans to make use of this authority.

Resolution 18 - Political Donations and expenditure Under the 2006 Act, political donations exceeding £5,000 in aggregate in any 12 month period to any political parties, independent election candidates or political organisations or the incurring of political expenditure are prohibited unless authorised by shareholders in advance. The Company does not, directly or through any subsidiary, make political donations or incur political expenditure within the ordinary meaning of those words and the Directors have no intention of using the authority for that purpose. The authority being requested from shareholders is not designed to change this. However, the definitions used in the 2006 Act are very broad and, as a result, it is possible that normal business activities (commonly accepted as a way of engaging with stakeholders to ensure that issues and concerns which are important to the Company are addressed) may be caught by the legislation. Activities of this nature are not designed to support any political party or to influence public support for a particular party. This resolution is proposed to ensure that the Company and its subsidiaries do not, because of any uncertainty due

to the broad nature of the definitions under the 2006 Act, unintentionally commit any technical breach of the 2006 Act.

Resolutions 19 and 20 - Disapplication of pre-emption rights

Resolutions 19 and 20, which will be proposed as special resolutions, would give the Directors the power to allot shares (or sell treasury shares) for cash, without first offering them to existing shareholders in proportion to their current holdings.

The power in resolution 19 would be limited (i) to allotments or sales under resolution 17 in connection with pre-emptive offers; or (ii) otherwise to allotments or sales up to an aggregate nominal amount of £1,890,000 (representing 18,900,000 ordinary shares of 10 pence each), which represents approximately 5% of the Company's issued share capital as at 13 June 2024 (being the latest practicable date prior to the publication of the Notice of Meeting).

The effect of resolution 20 is to empower the Directors to disapply statutory pre-emption rights in respect of an additional £1,890,000 (representing 18,900,000 ordinary shares of 10 pence each), which represents approximately 5% of the Company's issued share capital as at

13 June 2024 (being the latest practicable date prior to the publication of the Notice of Meeting).

08    Halma plc | Notice of Annual General Meeting 2024

In accordance with the Pre-Emption Group's Principles, the Directors confirm that the power under resolution 20 will be used only in connection with an acquisition or specified capital investment that is announced contemporaneously with the issue, or that has taken place in the preceding 12-month period and is disclosed in the announcement of the issue.

The Directors are aware of the Pre-Emption Group's most recent Statement of Principles on Disapplying Pre-emption Rights published in November 2022. However, at this time, the Directors consider it appropriate to retain the previous limits of 5% of the issued ordinary share capital of the Company in resolutions 19 and 20 and have not adopted the increased limits. The Directors will keep emerging market practice under review.

The powers in resolution 19 and resolution 20 will expire on the earlier of (i) the conclusion of the annual general meeting of the Company in 2025 and (ii) 30 September 2025.

The Director's confirm that they intend to follow the shareholder protections in paragraph one of Part 2B of the Statement of Principles on Disapplying Pre-Emption Rights, published by the Pre-Emption Group.

The Directors have no current plans to make use of these powers.

Resolution 21 - Authority to purchase own shares The Directors were authorised at the 2023 annual general meeting of the Company to purchase up to 37,900,000 of the Company's own 10p ordinary shares in the market. In accordance with the Directors' stated intention to seek annual renewal, this resolution (which will be proposed as a special resolution) will renew this authority until the earlier of (i) the conclusion of the annual general meeting of the Company in 2025 and (ii) 30 September 2025,

in respect of up to 37,900,000 ordinary shares, which is approximately 10% of the Company's issued share capital as at 13 June 2024 (being the latest practicable date prior to the publication of the Notice of Meeting).

The Directors have no present intention of exercising the authority to make market purchases. However, the Directors consider it desirable that the possibility of making such purchases, under appropriate circumstances, is available. The Directors will only make purchases under the authority where they believe that to do so would result in an increase in earnings per share for the remaining shareholders or where the purchased shares are to be used to satisfy awards made under employee share plans, and such purchases are considered to be in the best interests of shareholders generally.

Any shares purchased under the authority would be either held as treasury shares or cancelled. The Company does not currently hold any shares in treasury or have any outstanding options or warrants.

Resolution 22 - Notice of general meetings

Under the 2006 Act, the notice period for general meetings is 21 clear days' notice unless shareholders approve a shorter notice period, which cannot be less than 14 clear days. Annual general meetings must be held on at least 21 clear days' notice.

Resolution 22 seeks to renew the authority obtained at the 2023 annual general meeting of the Company allowing the Company to call general meetings (other than annual general meetings) on not less than 14 clear days' notice.

It is intended that a shorter notice period will not be used as a matter of routine for general meetings, but only if the flexibility would be helpful given the business of the meeting and where the Board thinks it is in the interest of shareholders as a whole. If the resolution is passed, the authority will be effective until the annual general meeting of the Company in 2025, when it is intended that a similar resolution will be proposed.

The Company offers the facility for shareholders to vote and appoint proxies by electronic means. This is accessible to all shareholders and would be available if the Company were to call a meeting on 14 clear days' notice.

Halma plc |  Notice of Annual General Meeting 2024    09

INFORMATION FOR SHAREHOLDERS

Entitlement to attend and vote

1. Entitlement to attend, speak and vote at the annual general meeting ('AGM') and the number of votes which may be cast at the AGM, will be determined by reference to the Register of Members of the Company at close of business on 23 July 2024 (or, in the event of any adjournment of the AGM, close of business on the date which is two days before the time of the adjourned meeting, provided that no account shall be taken of any part of a day that is not a working day). Changes to entries on the Register of Members after the relevant deadline shall be disregarded for the purpose of determining the rights of any person

to attend and vote at the relevant meeting.

Voting procedures

2. In line with best practice, all resolutions at the AGM will be taken on a poll vote. On a poll, each shareholder has one vote for every share held. The Directors believe a poll is more representative of shareholders' voting intentions because shareholders' votes are counted according to the number of shares held and all votes tendered are taken into account whether or not a shareholder is able to attend and vote in person. The results of voting at the AGM will be published on our website at www.halma.com and will be released via the London Stock Exchange plc as soon as possible following the AGM.

Appointment of proxies

  1. A shareholder entitled to attend and vote at the AGM is entitled to appoint a proxy or proxies to exercise all or any of a shareholder's rights at the AGM. A proxy does not need to be a shareholder of the Company. The return of a completed Proxy Form, other such instrument or any CREST Proxy Instruction (as described in paragraph 11) will not prevent a shareholder from attending the AGM and voting
    in person if he/she wishes to do so.
  2. A Proxy Form which may be used to make such appointment and give proxy instructions has been sent to all shareholders (except those who have elected to receive notice via email, who are able to appoint a proxy or proxies as described in paragraph 5).

5. In order to be valid, an appointment of a proxy or proxies must be completed, and returned, together with the power of attorney or other authority (if any) under which it is signed, or a duly certified copy of such authority, by one of the following methods:

  1. electronically via the Registrar's website at www.investorcentre.co.uk/eproxy using the Control Number, Shareholder Reference Number (SRN) and PIN;
  2. in hard copy form by post, courier or by hand, to the Company's Registrar, Computershare Investor Services PLC at The Pavilions, Bridgwater Road, Bristol, BS99 6ZY; or
  3. in the case of CREST members, by using the CREST electronic proxy appointment service (as set out in paragraph 11);

in each case so that it is received no later than 12.30pm on 23 July 2024 (or, in the event of any adjournment of the AGM, not less than 48 hours before the time fixed for the adjourned meeting, provided that no account shall be taken of any part of a day that is not a working day).

6. In the case of a joint holding, a proxy or proxies need only be signed by one joint holder. If more than one such joint holder completes a proxy appointment, the appointment submitted by the most senior holder shall be accepted to the exclusion of the votes of the other joint holders. Seniority is determined by the order in which the names appear in the Register of Members.

  1. If two or more valid but differing appointments of a proxy are received in respect of the same share for use at the same AGM, the appointment of the proxy which is last received before the latest time for the receipt of proxies (regardless of its date or the date of its signature) shall be treated as replacing the others as regards that share. If the Company is unable to determine which was last received, none of them shall be treated as valid in respect of that share.
  2. Proxymity Voting - if you are an institutional investor you may also be able to appoint a proxy electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Company's Registrar. For further information regarding Proxymity, please go to www.proxymity.io. Your proxy must be lodged by 12.30pm on 23 July 2024 in order to be considered valid (or, in the event of any adjournment of the AGM, not less than 48 hours before the time fixed for the adjourned meeting, provided that no account shall be taken of any part of a day that is not a working day). Before you can appoint a proxy via this process you will need to have agreed to Proxymity's associated terms and conditions. It is important that you read these carefully as you will be bound by them and they will govern the electronic appointment of your proxy.

10    Halma plc | Notice of Annual General Meeting 2024

Attention: This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Halma plc published this content on 24 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 June 2024 16:42:05 UTC.